Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme

  1. Miehlke, S.
  2. Schlag, C.
  3. Lucendo, A.J.
  4. Biedermann, L.
  5. Vaquero, C.S.
  6. Schmoecker, C.
  7. Hayat, J.
  8. Hruz, P.
  9. Ciriza de Los Rios, C.
  10. Bredenoord, A.J.
  11. Vieth, M.
  12. Schoepfer, A.
  13. Attwood, S.
  14. Mueller, R.
  15. Burrack, S.
  16. Greinwald, R.
  17. Straumann, A.
Aldizkaria:
United European gastroenterology journal

ISSN: 2050-6414

Argitalpen urtea: 2022

Alea: 10

Zenbakia: 3

Orrialdeak: 330-343

Mota: Artikulua

DOI: 10.1002/UEG2.12220 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus